Skip to main content
. 2022 Apr 24;14(5):927. doi: 10.3390/pharmaceutics14050927

Figure 7.

Figure 7

Effect of L-lysine α-oxidase, herceptin, and different nanoparticles treatment on histopathological changes in organs and tumor pathology. Kidney (a), liver (b), spleen (c), tumor (d). Where CS is chitosan, LO is L-lysine α-oxidase, PEG is polyethylene glycol 600, HER is herceptin (Trastuzumab).